Integrated BioPharma Q1 revenue $13.6M (+5.4% YoY); net income $0.3M vs loss

INTEGRATED BIOPHARMA INC

2025-Q1 EPS reported $0.01 revenue$13,617,000

Revenue $13.6M versus $12.9M YoY; operating income $0.5M versus operating loss of $54K.
Net income $259K ($0.01 diluted EPS) compared to net loss of $59K ($0.00) in prior year.
Two largest customers represented 85% of revenue (down from 91%), reflecting diversification.
No forward guidance or dividend changes were provided in the release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.